Moleculin Historical Financial Ratios
MBRX Stock | USD 1.27 0.01 0.79% |
Moleculin Biotech is lately reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Moleculin Biotech financial condition quickly.
Moleculin |
About Moleculin Financial Ratios Analysis
Moleculin BiotechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Moleculin Biotech investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Moleculin financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Moleculin Biotech history.
Moleculin Biotech Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most ratios from Moleculin Biotech's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Moleculin Biotech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moleculin Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Moleculin Stock please use our How to Invest in Moleculin Biotech guide.At this time, Moleculin Biotech's Price Book Value Ratio is fairly stable compared to the past year.
2022 | 2024 | 2025 (projected) | |
Net Debt To EBITDA | 1.4 | 0.7 | 0.94 |
Intangibles To Total Assets | 0.19 | 0.34 | 0.45 |
Moleculin Biotech fundamentals Correlations
Click cells to compare fundamentals
Moleculin Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Moleculin Biotech fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Ptb Ratio | 2.65 | 0.63 | 0.58 | 0.98 | 0.88 | 0.92 | |
Book Value Per Share | 27.06 | 44.09 | 27.37 | 13.2 | 15.18 | 14.42 | |
Free Cash Flow Yield | (0.39) | (0.38) | (0.91) | (0.95) | (1.09) | (1.04) | |
Operating Cash Flow Per Share | (27.07) | (10.58) | (14.49) | (12.2) | (10.98) | (11.53) | |
Capex To Depreciation | 1.88 | 0.12 | 0.52 | 0.98 | 1.12 | 2.06 | |
Pb Ratio | 2.65 | 0.63 | 0.58 | 0.98 | 0.88 | 0.92 | |
Free Cash Flow Per Share | (27.65) | (10.59) | (14.53) | (12.26) | (11.04) | (11.59) | |
Roic | (0.65) | (0.16) | (0.55) | (0.94) | (0.85) | (0.89) | |
Net Income Per Share | (22.85) | (4.94) | (14.37) | (15.07) | (13.56) | (14.24) | |
Days Of Inventory On Hand | 2.4K | (63.17) | (36.17) | 0.002874 | 0.003305 | 0.00314 | |
Payables Turnover | 0.25 | 0.19 | 0.11 | 0.0508 | 0.0458 | 0.0778 | |
Cash Per Share | 23.12 | 39.57 | 22.63 | 11.92 | 13.71 | 13.02 | |
Pocfratio | (2.65) | (2.64) | (1.1) | (1.06) | (0.95) | (1.0) | |
Capex To Operating Cash Flow | (0.0212) | (0.001003) | (0.002424) | (0.005145) | (0.004631) | (0.004862) | |
Pfcf Ratio | (2.59) | (2.64) | (1.09) | (1.05) | (0.95) | (0.99) | |
Days Payables Outstanding | 1.4K | 1.9K | 3.4K | 7.2K | 8.3K | 7.6K | |
Income Quality | 1.02 | 1.19 | 0.95 | 0.81 | 0.73 | 0.76 | |
Roe | (0.84) | (0.11) | (0.53) | (1.14) | (1.31) | (1.25) | |
Ev To Operating Cash Flow | (1.81) | 1.1 | 0.45 | (0.1) | (0.0922) | (0.0968) | |
Pe Ratio | (3.14) | (5.64) | (1.11) | (0.85) | (0.77) | (0.81) | |
Return On Tangible Assets | (0.84) | (0.12) | (0.59) | (1.1) | (0.99) | (1.04) | |
Ev To Free Cash Flow | (1.77) | 1.09 | 0.45 | (0.1) | (0.0918) | (0.0963) | |
Intangibles To Total Assets | 0.38 | 0.13 | 0.19 | 0.29 | 0.34 | 0.45 | |
Net Debt To E B I T D A | 0.78 | 0.76 | 3.1 | 1.4 | 0.7 | 0.94 | |
Current Ratio | 5.89 | 20.02 | 9.46 | 3.86 | 3.47 | 4.69 | |
Tangible Book Value Per Share | 10.07 | 37.87 | 21.52 | 7.55 | 6.8 | 13.3 | |
Graham Number | 117.94 | 70.04 | 94.08 | 66.89 | 76.92 | 73.08 | |
Shareholders Equity Per Share | 27.06 | 44.09 | 27.37 | 13.2 | 15.18 | 14.42 | |
Capex Per Share | 0.57 | 0.0106 | 0.0351 | 0.0628 | 0.0722 | 0.0686 | |
Graham Net Net | 7.36 | 36.73 | 19.88 | 5.81 | 5.23 | 4.97 | |
Interest Debt Per Share | 0.42 | 0.0887 | 0.24 | 0.29 | 0.33 | 0.32 | |
Enterprise Value Over E B I T D A | (1.65) | 0.91 | 0.41 | (0.0837) | (0.0753) | (0.0791) | |
Price Earnings Ratio | (3.14) | (5.64) | (1.11) | (0.85) | (0.77) | (0.81) | |
Operating Cycle | 2.4K | (63.17) | (36.17) | 0.002874 | 0.003305 | 0.00314 | |
Price Book Value Ratio | 2.65 | 0.63 | 0.58 | 0.98 | 0.88 | 0.92 | |
Price Earnings To Growth Ratio | 0.14 | 0.072 | (0.005795) | (0.18) | (0.2) | (0.19) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Moleculin Stock Analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.